MANE logo
MANE NYSE US

Veradermics, Incorporated Common Stock

Healthcare · Pharmaceuticals Website · IPO Feb 2026
$76.78
▲ +$3.43 (+4.68%)
Vol 20K
Mkt Cap
$2.6B
Beta
-2.36
52W
$32–$70

Wall Street Consensus

10 analysts · Apr 2026
5
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
90.0%
Buy Rating

Price Chart

Quarterly Revenue & Earnings

Quarter 2024-1… 2025-1…
Revenue
Net Income -$5.7M -$21.8M

Fundamentals Trend

Metric 2025-09-30 2025-12-31 2026-04-12
ROE (TTM)
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 0.00 0.00
Current Ratio 3.29 16.66 16.66

Key Ratios

52W High
$69.57
52W Low
$32.00
$32.00 52-Week Range $69.57

Financial Health

Free Cash Flow
-$23.6M
Net Debt
-$21.8M
Cash
$21.8M
Total Debt
$4K
As of Dec 31, 2025

How does MANE compare to Pharmaceuticals peers?

Peer group: Peers · Pharmaceuticals (Peers) · 10 companies

MANE valuation vs Pharmaceuticals peers

P/E ratio
0% below peers (28.3)
vs Peers
vs Industry
Fair value
P/S ratio
0% below peers (3.3)
vs Peers
vs Industry
Overvalued
P/B ratio
0% below peers (3.6)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.8%)
vs Peers
vs Industry
Low yield

MANE profitability vs Pharmaceuticals peers

ROE
0% below peers (-24.9%)
vs Peers
vs Industry
Top tier
Net margin
0% below peers (1.6%)
vs Peers
vs Industry
In line
Gross margin
0% below peers (69.6%)
vs Peers
vs Industry
In line
ROA
0% below peers (-1.4%)
vs Peers
vs Industry
Top tier

MANE financial health vs Pharmaceuticals peers

D/E ratio
0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
16.7
350% above peers (3.7)
vs Peers
vs Industry
Strong liquidity
Beta
-2.4
612% below peers (0.5)
vs Peers
vs Industry
More volatile

MANE fundamentals radar

MANE Peer median Industry

MANE profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

MANE vs peers: key metrics